<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03836898</url>
  </required_header>
  <id_info>
    <org_study_id>PhakicIOL Presbyopia</org_study_id>
    <nct_id>NCT03836898</nct_id>
  </id_info>
  <brief_title>Presbyopic Phakic Intraocular Lens for Myopia Correction</brief_title>
  <official_title>Presbyopic Phakic Intraocular Lens for Myopia Correction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gemini Eye Clinic</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gemini Eye Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective single-center study of implantations of the presbyopic version of
      phakic intraocular lens IPCL (EyeolUK, United Kingdom).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants are impanted with the phakic intraocular lens IPCL (EyeolUK, United Kingdom) and
      monitored during 2 years period. Visual acuity for near and distance is evaluated, along with
      refraction and endothelium cell density.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Actual">December 31, 2018</completion_date>
  <primary_completion_date type="Actual">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Uncorrected Distance Visual Acuity (UDVA)</measure>
    <time_frame>2 years</time_frame>
    <description>Distance visual acuity tested without any correction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Uncorrected Near Visual Acuity (UNVA)</measure>
    <time_frame>2 years</time_frame>
    <description>Near visual acuity tested without any correction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Corrected Distance Visual Acuity (CDVA)</measure>
    <time_frame>2 years</time_frame>
    <description>Distance visual acuity tested with correction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Corrected Near Visual Acuity (CNVA)</measure>
    <time_frame>2 years</time_frame>
    <description>Near visual acuity tested with correction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in distance refraction</measure>
    <time_frame>2 years</time_frame>
    <description>Expressed as spherical equivalent sp.Eq (D)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in near refraction</measure>
    <time_frame>2 years</time_frame>
    <description>Expressed as spherical equivalent sp.Eq (D)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Presbyopia</condition>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>Implantation phakic intraocular lens</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Presbyopic posterior chamber phakic intraocular lens IPCL implanted to the participants eye</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Presbyopic posterior chamber phakic intraocular lens IPCL</intervention_name>
    <description>Presbyopic posterior chamber phakic intraocular lens IPCL (EyeolUK, United Kingdom) has a refractive optic and diffractive trifocal pattern on its anterior optical surface to correct both distance and near refractive errors. Presbyopic addition is manufactured in a range of +1.0 to + 4.0 diopters (D) in 0.5 D steps.</description>
    <arm_group_label>Implantation phakic intraocular lens</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  CDVA &lt; 0.3 LogMAR

          -  Presbyopia with moderate to high myopia

          -  Phakic

        Exclusion Criteria:

          -  Corneal endotehleial cell density below 2000 cells/mm2

          -  Corneal dystrophies

          -  ACD less than 2.8 mm

          -  history or current uveitis

          -  acute ocular inflammation

          -  glaucoma

          -  chronic uveitis

          -  previous intraocular or refractive surgery

          -  preexisting ocular pathologic which may affect postoperative results
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>38 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Gemini Eye Clinic</name>
      <address>
        <city>Zl√≠n</city>
        <zip>760 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>February 6, 2019</study_first_submitted>
  <study_first_submitted_qc>February 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 11, 2019</study_first_posted>
  <last_update_submitted>May 9, 2019</last_update_submitted>
  <last_update_submitted_qc>May 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
    <mesh_term>Presbyopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

